Duygu ÜNDER

IMPACT OF A NEW CLINICAL PHARMACY CONSULTATION SYSTEM: A RETROSPECTIVE STUDY AT A TRAINING AND RESEARCH HOSPITAL IN TÜRKİYE

Duygu ÜNDER, Betül Özgan, Müzeyyen Aksoy, Enes Emir İlerler et autres

Objective: The clinical pharmacy specialization program (CPSEP), initiated in 2018, aims to train expert pharmacists for clinical pharmacy services in hospitals. No study has yet evaluated medication therapy recommendations within the first "clinical pharmacy consultation system (CPCS)" integrated into Türkiye’s hospital framework. …

tr (code pays fourni par la source)

Drug-induced hepatotoxicity among critically ill patients in the intensive care unit

Fethi Gül, Duygu ÜNDER

Background: Drug-induced liver injury (DILI) is a significant complication in intensive care unit (ICU) patients, driven by polypharmacy and critical illness. This study aimed to investigate the incidence, clinical characteristics, implicated agents, and outcomes of DILI in ICU patients. Methods: This retrospective, …

tr (code pays fourni par la source)

YENİ KLİNİK ECZACILIK KONSÜLTASYON SİSTEMİNİN ETKİSİ: TÜRKİYE'DEKİ BİR EĞİTİM VE ARAŞTIRMA HASTANESİNDE YAPILAN RETROSPEKTİF ÖN ÇALIŞMA

Duygu ÜNDER, Betül Özgan, Müzeyyen Aksoy, Enes Emir İlerler et autres

Clinical Pharmacist-Led Medication Review in Hospitalized Confirmed or Probable Patients with COVID-19 During the First Wave of COVID-19 Pandemic

Duygu ÜNDER, Cüneyd ENVER, Muhammed Yasir Demirci, Yunus Emre Ayhan et autres

Objectives: Drug-related problems (DRPs) result in serious problems among hospitalized patients, high rates of morbidity and mortality, and increased healthcare costs. This study aimed to identify DRPs by clinical pharmacist-led medication review in hospitalized probable patients with coronavirus disease-2019 (COVID-19) during the …

tr (code pays fourni par la source)

The Use of Direct Oral Anticoagulants in Atrial Fibrilation and Related Risk Groups: A Traditional Review

Yunus Emre Ayhan, Duygu ÜNDER, Enes Emir İlerler, İpek Midi et autres

Atriyal fibrilasyonu (AF) olan hastalarda tromboembolik olay riskini azaltmak için oral antikoagülanların rolü çok önemlidir. Bu amaçla, yaygın olarak kullanılan antikoagülan ilaç bir K vitamini antagonisti [vitamin K antagonist (VKA)] olan varfarindir. Fakat nonvalvüler AF'li hastalarda, diğer ilaçlarla minimum düzeyde etkileşime girmesi, …

tr (code pays fourni par la source)